These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10369477)

  • 21. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.
    Cox EH; Van Hemert JG; Tukker EJ; Danhof M
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):99-108. PubMed ID: 9403781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.
    Miller DR; Martineau RJ; Hull KA; Vallée F; LeBel M
    Can J Anaesth; 1994 Sep; 41(9):782-93. PubMed ID: 7954994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.
    Haschke M; Suter K; Hofmann S; Witschi R; Fröhlich J; Imanidis G; Drewe J; Briellmann TA; Dussy FE; Krähenbühl S; Surber C
    Br J Clin Pharmacol; 2010 Jun; 69(6):607-16. PubMed ID: 20565452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of midazolam and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats.
    Ma F; Lau CE
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):109-13. PubMed ID: 8832431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery.
    Somma J; Donner A; Zomorodi K; Sladen R; Ramsay J; Geller E; Shafer SL
    Anesthesiology; 1998 Dec; 89(6):1430-43. PubMed ID: 9856718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam.
    Tuk B; van Oostenbruggen MF; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1999 May; 289(2):1067-74. PubMed ID: 10215689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic modeling of the coexistence of stimulatory and sedative components for midazolam.
    Lau CE; Wang Y; Ma F
    Eur J Pharmacol; 1998 Apr; 346(2-3):131-44. PubMed ID: 9652352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
    Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
    Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
    Peeters MY; Prins SA; Knibbe CA; Dejongh J; Mathôt RA; Warris C; van Schaik RH; Tibboel D; Danhof M
    Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A; Karim A; Feldman J; Kharasch E
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
    Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.